SGLT2 Inhibition, Choline Metabolites, and Cardiometabolic Diseases: A Mediation Mendelian Randomization Study.
Xu M, Zheng J, Hou T, Lin H, Wang T, Wang S, Lu J, Zhao Z, Li M, Xu Y, Ning G, Bi Y, Wang W.
Xu M, et al. Among authors: wang w, wang t, wang s.
Diabetes Care. 2022 Nov 1;45(11):2718-2728. doi: 10.2337/dc22-0323.
Diabetes Care. 2022.
PMID: 36161993
Free PMC article.